393
Participants
Start Date
May 31, 2009
Primary Completion Date
September 30, 2010
Study Completion Date
September 30, 2010
Ethinylestradiol/Gestodene (FC Patch Low BAY86-5016)
0.55mg ethinylestradiol and 2.1mg gestodene
Norelgestromin/Ethinylestradiol (EVRA)
0.6mg ethinylestradiol and 6mg norelgestromin
Vienna
Vienna
Mödling
Wiener Neustadt
Innsbruck
Wörgl
Bregenz
Graz
Graz
Zeltweg
Prague
České Budějovice
Písek
Olomouc
Brno
Hradec Králové
Prague
Prague
Prague
De Bilt
Den Helder
Heerlen
Nijmegen